Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

2.

cDNA cloning and expression of a new form of human aryl sulfotransferase.

Zhu X, Veronese ME, Iocco P, McManus ME.

Int J Biochem Cell Biol. 1996 May;28(5):565-71.

PMID:
8697101
3.

Cytochromes P450, 1A2, and 2C9 are responsible for the human hepatic O-demethylation of R- and S-naproxen.

Miners JO, Coulter S, Tukey RH, Veronese ME, Birkett DJ.

Biochem Pharmacol. 1996 Apr 26;51(8):1003-8.

PMID:
8866821
4.

Photoaffinity labeling of human recombinant sulfotransferases with 2-azidoadenosine 3',5'-[5'-32P]bisphosphate.

Radominska A, Drake RR, Zhu X, Veronese ME, Little JM, Nowell S, McManus ME, Lester R, Falany CN.

J Biol Chem. 1996 Feb 9;271(6):3195-9.

5.

Human cytochrome P450 isoform specificity in the regioselective metabolism of toluene and o-, m- and p-xylene.

Tassaneeyakul W, Birkett DJ, Edwards JW, Veronese ME, Tassaneeyakul W, Tukey RH, Miners JO.

J Pharmacol Exp Ther. 1996 Jan;276(1):101-8.

PMID:
8558417
6.

Human hepatic cytochrome P450 2C9 catalyzes the rate-limiting pathway of torsemide metabolism.

Miners JO, Rees DL, Valente L, Veronese ME, Birkett DJ.

J Pharmacol Exp Ther. 1995 Mar;272(3):1076-81.

PMID:
7891318
7.

Direct characterization of the selectivity of furafylline as an inhibitor of human cytochromes P450 1A1 and 1A2.

Tassaneeyakul W, Birkett DJ, Veronese ME, McManus ME, Tukey RH, Miners JO.

Pharmacogenetics. 1994 Oct;4(5):281-4. No abstract available.

PMID:
7894501
9.

Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms.

Andersson T, Miners JO, Veronese ME, Birkett DJ.

Br J Clin Pharmacol. 1994 Aug;38(2):131-7.

10.

Heterologous systems for expression of mammalian sulfotransferases.

Veronese ME, Burgess W, Cruickshank D, Sansom L, Zhu X, McManus ME.

Chem Biol Interact. 1994 Jun;92(1-3):77-85.

PMID:
8033272
11.

Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism.

Andersson T, Miners JO, Veronese ME, Birkett DJ.

Br J Clin Pharmacol. 1994 Jun;37(6):597-604.

12.

Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A2, 2E1 and 3A isoforms.

Tassaneeyakul W, Birkett DJ, McManus ME, Tassaneeyakul W, Veronese ME, Andersson T, Tukey RH, Miners JO.

Biochem Pharmacol. 1994 May 18;47(10):1767-76.

PMID:
8204093
13.

In vitro proguanil activation to cycloguanil by human liver microsomes is mediated by CYP3A isoforms as well as by S-mephenytoin hydroxylase.

Birkett DJ, Rees D, Andersson T, Gonzalez FJ, Miners JO, Veronese ME.

Br J Clin Pharmacol. 1994 May;37(5):413-20.

14.

Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques.

Tassaneeyakul W, Veronese ME, Birkett DJ, Gonzalez FJ, Miners JO.

Biochem Pharmacol. 1993 Dec 3;46(11):1975-81.

PMID:
8267647
15.

Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism.

Andersson T, Miners JO, Veronese ME, Tassaneeyakul W, Tassaneeyakul W, Meyer UA, Birkett DJ.

Br J Clin Pharmacol. 1993 Dec;36(6):521-30.

16.

High-performance liquid chromatographic assay for human liver microsomal omeprazole metabolism.

Andersson T, Lagerstrøm PO, Miners JO, Veronese ME, Weidolf L, Birkett DJ.

J Chromatogr. 1993 Sep 22;619(2):291-7.

PMID:
8263101
17.

Identification of two human brain aryl sulfotransferase cDNAs.

Zhu X, Veronese ME, Bernard CC, Sansom LN, McManus ME.

Biochem Biophys Res Commun. 1993 Aug 31;195(1):120-7.

PMID:
8363592
18.

In vitro approaches can predict human drug metabolism.

Bickett DJ, MacKenzie PI, Veronese ME, Miners JO.

Trends Pharmacol Sci. 1993 Aug;14(8):292-4. Review. No abstract available.

PMID:
8249146
19.
20.

Molecular characterisation of a human aryl sulfotransferase cDNA.

Zhu X, Veronese ME, Sansom LN, McManus ME.

Biochem Biophys Res Commun. 1993 Apr 30;192(2):671-6.

PMID:
8484775
21.

Tolbutamide hydroxylation in humans: lack of bimodality in 106 healthy subjects.

Veronese ME, Miners JO, Rees DL, Birkett DJ.

Pharmacogenetics. 1993 Apr;3(2):86-93.

PMID:
8518838
22.

Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.

Tassaneeyakul W, Birkett DJ, Veronese ME, McManus ME, Tukey RH, Quattrochi LC, Gelboin HV, Miners JO.

J Pharmacol Exp Ther. 1993 Apr;265(1):401-7.

PMID:
8474022
23.

cDNA expression studies of rat liver aryl sulphotransferase.

Cruickshank D, Sansom LN, Veronese ME, Mojarrabi B, McManus ME, Zhu X.

Biochem Biophys Res Commun. 1993 Feb 26;191(1):295-301.

PMID:
8447833
24.

Site-directed mutation studies of human liver cytochrome P-450 isoenzymes in the CYP2C subfamily.

Veronese ME, Doecke CJ, Mackenzie PI, McManus ME, Miners JO, Rees DL, Gasser R, Meyer UA, Birkett DJ.

Biochem J. 1993 Jan 15;289 ( Pt 2):533-8.

25.

Co-regulation of phenytoin and tolbutamide metabolism in humans.

Tassaneeyakul W, Veronese ME, Birkett DJ, Doecke CJ, McManus ME, Sansom LN, Miners JO.

Br J Clin Pharmacol. 1992 Dec;34(6):494-8.

26.

Caffeine as a probe for human cytochromes P450: validation using cDNA-expression, immunoinhibition and microsomal kinetic and inhibitor techniques.

Tassaneeyakul W, Mohamed Z, Birkett DJ, McManus ME, Veronese ME, Tukey RH, Quattrochi LC, Gonzalez FJ, Miners JO.

Pharmacogenetics. 1992 Aug;2(4):173-83.

PMID:
1306118
27.

Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9.

Veronese ME, Mackenzie PI, Doecke CJ, McManus ME, Miners JO, Birkett DJ.

Biochem Biophys Res Commun. 1991 Mar 29;175(3):1112-8. Erratum in: Biochem Biophys Res Commun 1991 Nov 14;180(3);1527.

PMID:
2025243
28.

Relationship between phenytoin and tolbutamide hydroxylations in human liver microsomes.

Doecke CJ, Veronese ME, Pond SM, Miners JO, Birkett DJ, Sansom LN, McManus ME.

Br J Clin Pharmacol. 1991 Feb;31(2):125-30.

29.

Metabolism of paracetamol and phenacetin in relation to debrisoquine oxidation phenotype.

Veronese ME, McLean S.

Eur J Clin Pharmacol. 1991;40(6):547-52.

PMID:
1884734
30.

Debrisoquine oxidation polymorphism in a Tasmanian population.

Veronese ME, McLean S.

Eur J Clin Pharmacol. 1991;40(5):529-32.

PMID:
1884730
31.

Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine (PhIP) by liver microsomes and isolated rabbit cytochrome P450 isozymes.

Turteltaub KW, Knize MG, Buonarati MH, McManus ME, Veronese ME, Mazrimas JA, Felton JS.

Carcinogenesis. 1990 Jun;11(6):941-6.

PMID:
2347068
32.

Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450.

McManus ME, Burgess WM, Veronese ME, Huggett A, Quattrochi LC, Tukey RH.

Cancer Res. 1990 Jun 1;50(11):3367-76.

33.

Tolbutamide hydroxylation by human, rabbit and rat liver microsomes and by purified forms of cytochrome P-450.

Veronese ME, McManus ME, Laupattarakasem P, Miners JO, Birkett DJ.

Drug Metab Dispos. 1990 May-Jun;18(3):356-61.

PMID:
1974199
34.

Validation of the tolbutamide metabolic ratio for population screening with use of sulfaphenazole to produce model phenotypic poor metabolizers.

Veronese ME, Miners JO, Randles D, Gregov D, Birkett DJ.

Clin Pharmacol Ther. 1990 Mar;47(3):403-11.

PMID:
2311340
35.

Metabolism of food derived mutagens and 2-acetylaminofluorene by purified rabbit and cDNA expressed human cytochromes P450.

McManus ME, Burgess WM, Veronese ME, Felton JS, Knize MG, Snyderwine EG, Quattrochi LC, Tukey RH.

Prog Clin Biol Res. 1990;340E:139-47. No abstract available.

PMID:
2392457
36.

Activation of the food-derived mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by rabbit and human liver microsomes and purified forms of cytochrome P-450.

McManus ME, Felton JS, Knize MG, Burgess WM, Roberts-Thomson S, Pond SM, Stupans I, Veronese ME.

Carcinogenesis. 1989 Feb;10(2):357-63.

PMID:
2912586
37.
38.

Tolbutamide hydroxylation by human liver microsomes. Kinetic characterisation and relationship to other cytochrome P-450 dependent xenobiotic oxidations.

Miners JO, Smith KJ, Robson RA, McManus ME, Veronese ME, Birkett DJ.

Biochem Pharmacol. 1988 Mar 15;37(6):1137-44.

PMID:
3355588
39.

Formation of reactive metabolites of phenacetin in humans and rats.

Veronese ME, McLean S, D'Souza CA, Davies NW.

Xenobiotica. 1985 Nov;15(11):929-40.

PMID:
4082633
40.

Value of hepatic computerized tomographic scanning during amiodarone therapy.

Markos J, Veronese ME, Nicholson MR, McLean S, Shevland JE.

Am J Cardiol. 1985 Jul 1;56(1):89-92.

PMID:
4014047
41.

Supplemental Content

Loading ...
Support Center